Agarwal K N, Bhasin S K
Department of Paediatrics, University College of Medical Sciences and GTB Hospital, Delhi, India.
Eur J Clin Nutr. 2002 Dec;56 Suppl 4:S56-9. doi: 10.1038/sj.ejcn.1601664.
The aim of this work was to study feasibility of diarrhoea control in children (6 months to 5 y of age) by feeding fermented milk preparations. The design used was a randomized controlled clinical trial and the study was carried out at the Delhi University College Hospital providing tertiary care, and a nearby community centre Nand Nagri, a resettlement colony in East Delhi. Children suffering from acute diarrhoea (75 patients from the hospital and 75 from the community) were allocated to three groups by double-blind technique. Group 1 was given a fermented milk, Actimel, containing 10(8) of each Lactobacillus casei DN-114001, Lactobacillus bulgaricus and Streptococcus thermophilus per gram. Group 2 was given Indian Dahi (Lf 40) containing 10(8) of each Lactococcus lactis, Lactococcus lactis cremoris and Leuconostac mesenteroides cremoris per gram. Group 3 was given ultra-heat-treated yoghurt preparation (no live bacteria). Actimel was also used as a starter to prepare the curd in order to study the preventive effect of diarrhoea in children in a community. In the hospital study Indian Dahi and Actimel administration reduced mean duration of diarrhoea by 0.3 and 0.6 day (P<0.001), respectively. The corresponding figures in the community study were 0.2 and 0.5 day (P<0.05), respectively. The families using Actimel as a starter showed a reduction in diarrhoeal morbidity episodes by 40% of the children tested in a 3 month follow-up. In conclusion, Actimel, fermented milk containing Lactobacillus casei DN-114001, and Indian Dahi can significantly reduce the duration of diarrhoea in children; the former preparation being superior.
这项工作的目的是研究通过喂食发酵乳制剂来控制儿童(6个月至5岁)腹泻的可行性。采用的设计是随机对照临床试验,研究在提供三级护理的德里大学学院医院以及附近东德里的一个安置区社区中心南纳格里进行。患有急性腹泻的儿童(75名来自医院,75名来自社区)通过双盲技术被分为三组。第1组给予一种发酵乳Actimel,每克含有10⁸个干酪乳杆菌DN - 114001、保加利亚乳杆菌和嗜热链球菌。第2组给予印度达希(Lf 40),每克含有10⁸个乳酸乳球菌、乳酸乳球菌乳脂亚种和肠膜明串珠菌乳脂亚种。第3组给予超高温处理的酸奶制剂(无活菌)。Actimel还被用作制作凝乳的发酵剂,以研究其对社区儿童腹泻的预防作用。在医院研究中,给予印度达希和Actimel分别使腹泻平均持续时间缩短了0.3天和0.6天(P<0.001)。社区研究中的相应数字分别为0.2天和0.5天(P<0.05)。在3个月的随访中,将Actimel用作发酵剂的家庭中,接受测试的儿童腹泻发病次数减少了40%。总之,含有干酪乳杆菌DN - 114001的发酵乳Actimel和印度达希可显著缩短儿童腹泻的持续时间;前一种制剂效果更佳。